Skip to content
← Back to this collection

PUBLICATIONS · 24101040

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 Nov 10
First author
Gilbert MR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 20;32(15):1633-4. doi: 10.1200/JCO.2013.54.6226.
    note
    Source null
    related pmid
    24752051
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2014 May 20;32(15):1634-5. doi: 10.1200/JCO.2013.54.9717.
    note
    Source null
    related pmid
    24752060
    relationship
    Comment in

Authors and identifiers

  1. name
    Gilbert MR
    type
    Author
  2. name
    Wang M
    type
    Author
  3. name
    Aldape KD
    type
    Author
  4. name
    Stupp R
    type
    Author
  5. name
    Hegi ME
    type
    Author
  6. name
    Jaeckle KA
    type
    Author
  7. name
    Armstrong TS
    type
    Author
  8. name
    Wefel JS
    type
    Author
  9. name
    Won M
    type
    Author
  10. name
    Blumenthal DT
    type
    Author
  11. name
    Mahajan A
    type
    Author
  12. name
    Schultz CJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gilbert MR
    type
    Author
  2. name
    Wang M
    type
    Author
  3. name
    Aldape KD
    type
    Author
  4. name
    Stupp R
    type
    Author
  5. name
    Hegi ME
    type
    Author
  6. name
    Jaeckle KA
    type
    Author
  7. name
    Armstrong TS
    type
    Author
  8. name
    Wefel JS
    type
    Author
  9. name
    Won M
    type
    Author
  10. name
    Blumenthal DT
    type
    Author
  11. name
    Mahajan A
    type
    Author
  12. name
    Schultz CJ
    type
    Author
bibliography ids
  1. nci-bib-48af5fb875e2c78cc92d50af
book metadata
content sha256
4e24e7e23d6527b891a82c87cb59e1d07e9dcc837b76aefae5f32fedfa2d70c8
document type
citation
dois
  1. 10.1200/JCO.2013.49.6968
electronic publication date
display
2013 Oct 7
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24101040
immutable id
pubmed:24101040@4e24e7e23d6527b891a82c87cb59e1d07e9dcc837b76aefae5f32fedfa2d70c8
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
32
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4085-91
volume
31
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 May 20;32(15):1633-4. doi: 10.1200/JCO.2013.54.6226.
    note
    Source null
    related pmid
    24752051
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2014 May 20;32(15):1634-5. doi: 10.1200/JCO.2013.54.9717.
    note
    Source null
    related pmid
    24752060
    relationship
    Comment in
outcomes validated
false
pmid
24101040
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
cbdd74b48caf4a295db209bf2778b915611a53bdfb6a8294373721c65c5d6bf1
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2013 Nov 10
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24101040/
title
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Preserved source evidence · Not medical advice